These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 15046253)

  • 1. Molecular mechanisms and biological significance of CTL avidity.
    Snyder JT; Alexander-Miller MA; Berzofskyl JA; Belyakov IM
    Curr HIV Res; 2003 Jul; 1(3):287-94. PubMed ID: 15046253
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective induction of high avidity CTL by altering the balance of signals from APC.
    Oh S; Hodge JW; Ahlers JD; Burke DS; Schlom J; Berzofsky JA
    J Immunol; 2003 Mar; 170(5):2523-30. PubMed ID: 12594278
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms of Antiviral Cytotoxic CD4 T Cell Differentiation.
    Knudson CJ; Férez M; Alves-Peixoto P; Erkes DA; Melo-Silva CR; Tang L; Snyder CM; Sigal LJ
    J Virol; 2021 Sep; 95(19):e0056621. PubMed ID: 34260270
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glu227-->Lys substitution in the acidic loop of major histocompatibility complex class I alpha 3 domain distinguishes low avidity CD8 coreceptor and avidity-enhanced CD8 accessory functions.
    Shen L; Potter TA; Kane KP
    J Exp Med; 1996 Nov; 184(5):1671-83. PubMed ID: 8920857
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of higher-avidity human CTLs by vector-mediated enhanced costimulation of antigen-presenting cells.
    Yang S; Tsang KY; Schlom J
    Clin Cancer Res; 2005 Aug; 11(15):5603-15. PubMed ID: 16061879
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High avidity CD8+ T cells efficiently eliminate motile HIV-infected targets and execute a locally focused program of anti-viral function.
    Foley MH; Forcier T; McAndrew E; Gonzalez M; Chen H; Juelg B; Walker BD; Irvine DJ
    PLoS One; 2014; 9(2):e87873. PubMed ID: 24551068
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel functional CTL avidity/activity compartmentalization to the site of mucosal immunization contributes to protection of macaques against simian/human immunodeficiency viral depletion of mucosal CD4+ T cells.
    Belyakov IM; Isakov D; Zhu Q; Dzutsev A; Berzofsky JA
    J Immunol; 2007 Jun; 178(11):7211-21. PubMed ID: 17513770
    [TBL] [Abstract][Full Text] [Related]  

  • 8. T cell tolerance based on avidity thresholds rather than complete deletion allows maintenance of maximal repertoire diversity.
    Sandberg JK; Franksson L; Sundbäck J; Michaelsson J; Petersson M; Achour A; Wallin RP; Sherman NE; Bergman T; Jörnvall H; Hunt DF; Kiessling R; Kärre K
    J Immunol; 2000 Jul; 165(1):25-33. PubMed ID: 10861031
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Viral peptide specific cytotoxic T lymphocytes are of high avidity to host-MHC but only low avidity to donor-MHC after allogeneic bone marrow transplantation.
    Kyburz D; Speiser DE
    Transpl Immunol; 1995 Jun; 3(2):143-50. PubMed ID: 7582905
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of CTL function among high-avidity tumor-specific CD8+ T cells following tumor infiltration.
    Janicki CN; Jenkinson SR; Williams NA; Morgan DJ
    Cancer Res; 2008 Apr; 68(8):2993-3000. PubMed ID: 18413769
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced suppression of polyclonal CD8
    Mu C; Zhang X; Wang L; Xu A; Ahmed KA; Pang X; Chibbar R; Freywald A; Huang J; Zhu Y; Xiang J
    J Leukoc Biol; 2017 May; 101(5):1221-1231. PubMed ID: 28096300
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The HIV-1 HLA-A2-SLYNTVATL is a help-independent CTL epitope.
    Kan-Mitchell J; Bisikirska B; Wong-Staal F; Schaubert KL; Bajcz M; Bereta M
    J Immunol; 2004 May; 172(9):5249-61. PubMed ID: 15100263
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimal colocalization of TCR and CD8 as a novel mechanism for the control of functional avidity.
    Cawthon AG; Alexander-Miller MA
    J Immunol; 2002 Oct; 169(7):3492-8. PubMed ID: 12244138
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective expansion of high- or low-avidity cytotoxic T lymphocytes and efficacy for adoptive immunotherapy.
    Alexander-Miller MA; Leggatt GR; Berzofsky JA
    Proc Natl Acad Sci U S A; 1996 Apr; 93(9):4102-7. PubMed ID: 8633023
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary proliferative and cytotoxic T-cell responses to HIV induced in vitro by human dendritic cells.
    Macatonia SE; Patterson S; Knight SC
    Immunology; 1991 Nov; 74(3):399-406. PubMed ID: 1769689
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor cells endowed with professional antigen-presenting cell functions prime PBLs to generate antitumor CTLs.
    Chiozzini C; Olivetta E; Sanchez M; Arenaccio C; Ferrantelli F; Leone P; Federico M
    J Mol Med (Berl); 2019 Aug; 97(8):1139-1153. PubMed ID: 31161312
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative clonal analysis of human immunodeficiency virus type 1 (HIV-1)-specific CD4+ and CD8+ cytolytic T lymphocytes isolated from seronegative humans immunized with candidate HIV-1 vaccines.
    Hammond SA; Bollinger RC; Stanhope PE; Quinn TC; Schwartz D; Clements ML; Siliciano RF
    J Exp Med; 1992 Dec; 176(6):1531-42. PubMed ID: 1460417
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential susceptibility of cells expressing allogeneic MHC or viral antigen to killing by antigen-specific CTL.
    Lee K; Takenaka H; Yoneda Y; Goto T; Sano K; Nakanishi M; Eguchi A; Okada M; Tashiro J; Sakurai K; Kubota T; Yoshida R
    Microbiol Immunol; 2004; 48(1):15-25. PubMed ID: 14734854
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antimelanoma activity of CTL generated from peripheral blood mononuclear cells after stimulation with autologous dendritic cells pulsed with melanoma gp100 peptide G209-2M is correlated to TCR avidity.
    Yang S; Linette GP; Longerich S; Haluska FG
    J Immunol; 2002 Jul; 169(1):531-9. PubMed ID: 12077285
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathogenesis of mousepox in H-2(d) mice: evidence for MHC class I-restricted CD8(+) and MHC class II-restricted CD4(+) CTL antiviral activity in the lymph nodes, spleen and skin, but not in the conjunctivae.
    Cespedes IS; Toka FN; Schollenberger A; Gieryńska M; Niemiałtowski M
    Microbes Infect; 2001 Nov; 3(13):1063-72. PubMed ID: 11709286
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.